Get started
Author

Megan M. Ellis

Observed names: Ellis, Megan M., M Ellis, Megan Ellis
ORCID: 0009-0008-2743-1165
Observed ORCID: 0009-0008-2743-1165
OpenAlex ID: A5043659621
Nationwide Exposure of U.S. Working Dogs to the Chagas Disease Parasite, Trypanosoma cruzi
2020 · Alyssa C. Meyers, Julia C. Purnell, et al. · American Journal of Tropical Medicine and Hygiene · 38
PDF
Selected cardiac abnormalities in Trypanosoma cruzi serologically positive, discordant, and negative working dogs along the Texas-Mexico border
2020 · Alyssa C. Meyers, Megan M. Ellis, et al. · BMC Veterinary Research · 21
PDF
Abstract 2644: Antibody-drug conjugates (ADCs) with a novel DNA-alkylating agent, DGN462, are highly potent in vitro and in vivo against human cancer models
2014 · Kathleen Whiteman, Charlene Audette, et al. · Cancer Research · 6
Physical performance is enhanced in old mice fed a short term diet medicated with rapamycin, acarbose, and phenylbutyrate
2021 · Physical performance is enhanced in old mice fed a short term diet medicated with rapamycin, acarbose, and phenylbutyrate, Megan Ellis, et al. · Aging Pathobiology and Therapeutics · 2
PDF
Abstract C160: New class of DNA-alkylating agents with a suitable tolerability profile created for use in antibody-drug conjugates (ADCs).
2013 · Michael Miller, Nathan Fishkin, et al. · Molecular Cancer Therapeutics · 2
Abstract B195: Lorvotuzumab mertansine displays favorable pharmacokinetics and tumor delivery in mouse models.
2011 · Xiuxia Sun, Lauren Clancy, et al. · Molecular Cancer Therapeutics · 2
A multi-center phase II study of three doses of TAS-108 in postmenopausal women with advanced breast carcinoma following first or second line endocrine therapy.
2009 · A Buzdar, E Tan-Chiu, et al. · Cancer Research
Works count: 9
Citation count: 71
H-index: 3
I10-index: 2
Year
Topic
Type